Sep 11, 2023 / 04:15PM GMT
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Great. Well, thanks for joining us, everybody. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley, and we're very pleased to be hosting Pfizer today. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. Today from the company, we have Angela Hwang, who is CCO and President of the Biopharma segment at Pfizer; and Suneet Varma, who is Global Oncology and U.S. President, also within the Biopharma Group.
Thanks so much both for joining us today. Really appreciate the time.
Suneet Varma - Pfizer Inc. - Global & U.S. President of Oncology
Thank you.
Questions and Answers:
Terence C. Flynn - Morgan Stanley, Research Division - Equity AnalystI thought maybe to start off, a question we get a lot from investors is just the 6% revenue growth guidance that